Effect of SynagisⓇ (palivizumab) prophylaxis on readmission due to respiratory syncytial virus in very low birth weight infants
Purpose : The aim of this study was to determine the efficacy of SynagisⓇ (palivizumab) in reducing the respiratory syncytial virus (RSV) readmission rate in very low birth weight infants (VLBWI ) and the subgroup that showed the most effective vaccination....
Saved in:
Main Authors: | Soo Kyoung Park (Author), Yu Jin Jung (Author), Hye Soo Yoo (Author), So Yoon Ahn (Author), Hyun Joo Seo (Author), Seo Heui Choi (Author), Myo Jing Kim (Author), Ga Won Jeon (Author), Soo Hyun Koo (Author), Kyung-Hoon Lee (Author), Yun Sil Chang (Author), Won Soon Park (Author) |
---|---|
Format: | Book |
Published: |
Korean Pediatric Society,
2010-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subcutaneous palivizumab (Synagis®) administration in an infant with congenital type 2B von Willebrand disease
by: Karel Allegaert, et al.
Published: (2015) -
Analysis of prognostic factors of laparotomy for necrotizing enterocolitis in extremely low birth weight infants
by: Jin Kyu Kim, et al.
Published: (2010) -
Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children
by: Natividad Viguria, et al.
Published: (2021) -
Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
by: Bernhard Resch
Published: (2017) -
THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
by: A. V. Rudakova, et al.
Published: (2012)